0
When any type of cancer metastasizes and spreads to the bone or other organs, this is very serious.
Only a trained Doctor Who looks at the pathology of patient who has cancer that has spread to the bone can make such a diagnosis.
What else can I help you with?
What cells does prostate cancer affect?
Prostate Cancer originates in the Male Prostate, however it can metastasize, or spread to other areas of the body.
Why would the scan show bone abnormalties in prostate cancer?
Late stage prostate cancer metasticizes to the bones. This may be the reason.
What is the prognosis for Prostate cancer and skin cancer and bone cancer he is also taking insuline 4 times a day?
Hahahaahahahaha you have cancer
Where can prostate cancer spread to?
Prostate cancer can spread to the bone, liver and lung and other parts of body. In most cases of prostate cancer metastasis occur in the lymph nodes and the bones. It's metastasis occurs when cells break away from the tumor in the prostate. nutrition2000.com
What happens to acid phosphatase levels when prostate cancer spreads to other parts of the body?
When prostate cancer spreads to other parts of the body, such as the bones, the acid phosphatase levels may increase. Acid phosphatase is an enzyme that can be elevated in cases of bone metastasis from prostate cancer, as it is released by prostate cancer cells in the bones. Monitoring acid phosphatase levels can help in assessing the extent of metastasis and response to treatment.
What is hardening of prostate?
The prostate is a small gland in men. It is part of the male reproductive system. Prostate hardening is caused by the development of cancer in the prostate. As cancer develops the tissue of prostate changes texture and hardness. symptoms of prostate cancer may include blood in the urine or semen, problems with erections, loss of bladder control, and bone pain in the lower back, hips or ribs. nutrition2000.com
What is the longevity with prostate bone cancer?
The prognosis for prostate cancer that has spread to the bones, known as metastatic prostate cancer, varies widely depending on several factors, including the extent of the spread, response to treatment, and overall health of the individual. In general, the average survival rate for metastatic prostate cancer is around 3-5 years. However, with advancements in treatment options such as hormone therapy, chemotherapy, and targeted therapies, some individuals may live longer than this average, while others may have a shorter lifespan. It is important for individuals with prostate bone cancer to work closely with their healthcare team to determine the most appropriate treatment plan for their specific situation.
What are the release dates for Healthy Body Healthy Mind - 2003 Advanced Prostate Cancer and Bone Loss 16-2?
Healthy Body Healthy Mind - 2003 Advanced Prostate Cancer and Bone Loss 16-2 was released on: USA: 8 April 2010
What is PC3 cells?
PC3 cells are a human prostate adenocarcinoma cell line frequently used in cancer research. They are derived from metastatic bone lesions and are known for their androgen receptor-independent growth, making them valuable for studying hormone-independent prostate cancer. PC3 cells exhibit aggressive behavior and are commonly used to investigate mechanisms of prostate cancer progression and potential therapeutic targets.
Is metastatic prostate cancer dangerous?
Metastatic prostate cancer is indeed considered dangerous due to its potential to spread to other parts of the body and its resistance to curative treatments. When prostate cancer metastasizes, it means that cancer cells have travelled from the prostate gland to other organs or tissues, such as the bones, lymph nodes, liver, or lungs. Metastatic prostate cancer is associated with poorer outcomes and a higher risk of complications compared to localized or early-stage prostate cancer. Once the cancer has spread beyond the prostate, it becomes more challenging to treat and manage effectively. Metastatic prostate cancer can lead to symptoms such as bone pain, urinary problems, fatigue, weight loss, and complications related to the spread of cancer to vital organs. Despite the challenges posed by metastatic prostate cancer, there are treatment options available to help manage the disease and improve quality of life. These may include hormone therapy, chemotherapy, targeted therapy, immunotherapy, radiation therapy, bone-targeted therapy, and palliative care. The goal of treatment for metastatic prostate cancer is often focused on controlling the spread of the disease, relieving symptoms, and prolonging survival. It's important for individuals with metastatic prostate cancer to work closely with their healthcare team to develop a personalized treatment plan tailored to their specific needs and preferences. Additionally, ongoing monitoring and supportive care are essential components of managing metastatic prostate cancer and optimizing outcomes for patients.
What is the medical term meaning cancer of the bone?
Most cases of bone marrow cancer are a result of cancer cells entering the bone marrow from other cancers in the body, such as Breast cancer, prostate cancer, or lung cancer. The primary bone cancers are called osteosarcoma, chondrosarcoma, Ewing's sarcoma, and malignant fibrous histiocytoma. Then there are other kinds of bone marrow cancers that are associated with a dysfunction in the development of blood cells that start out as pluripotent stem cells. These cncers include leukemia and lymphomas. A type of bone cancer that ocurrs in the red bone marrow is called multiple MYELOMA.
How is radium used in prostrate cancer?
Radium-223 chloride (Xofigo) is a radioactive drug used to treat prostate cancer that has spread to the bones. It works by delivering targeted radiation directly to bone metastases, which helps reduce pain and improve overall survival in patients with advanced prostate cancer. Radium-223 can help improve quality of life by reducing bone pain and delaying the progression of the disease.
